Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377
https://doi.org/10.1007/s12539-024-00609-y




## **GraphsformerCPI: Graph Transformer for Compound‚ÄìProtein** **Interaction Prediction**

**Jun Ma** **[1,2]** **[¬∑ Zhili Zhao](https://orcid.org/0000-0002-6645-0579)** **[1]** **¬∑ Tongfeng Li** **[1,3]** **¬∑ Yunwu Liu** **[1]** **¬∑ Jun Ma** **[1]** **[¬∑ Ruisheng Zhang](https://orcid.org/0000-0002-5086-7572)** **[1]**


Received: 7 August 2023 / Revised: 1 January 2024 / Accepted: 8 January 2024 / Published online: 8 March 2024
¬© International Association of Scientists in the Interdisciplinary Areas 2024


**Abstract**

Accurately predicting compound‚Äìprotein interactions (CPI) is a critical task in computer-aided drug design. In recent years,
the exponential growth of compound activity and biomedical data has highlighted the need for efficient and interpretable
prediction approaches. In this study, we propose GraphsformerCPI, an end-to-end deep learning framework that improves
prediction performance and interpretability. GraphsformerCPI treats compounds and proteins as sequences of nodes with
spatial structures, and leverages novel structure-enhanced self-attention mechanisms to integrate semantic and graph structural features within molecules for deep molecule representations. To capture the vital association between compound atoms
and protein residues, we devise a dual-attention mechanism to effectively extract relational features through .cross-mapping.
By extending the powerful learning capabilities of Transformers to spatial structures and extensively utilizing attention
mechanisms, our model offers strong interpretability, a significant advantage over most black-box deep learning methods.
To evaluate GraphsformerCPI, extensive experiments were conducted on benchmark datasets including human, _C. elegans_,
Davis and KIBA datasets. We explored the impact of model depth and dropout rate on performance and compared our
model against state-of-the-art baseline models. Our results demonstrate that GraphsformerCPI outperforms baseline models
in classification datasets and achieves competitive performance in regression datasets. Specifically, on the human dataset,
GraphsformerCPI achieves an average improvement of 1.6% in AUC, 0.5% in precision, and 5.3% in recall. On the KIBA
dataset, the average improvement in Concordance index (CI) and mean squared error (MSE) is 3.3% and 7.2%, respectively.
Molecular docking shows that our model provides novel insights into the intrinsic interactions and binding mechanisms.
Our research holds practical significance in effectively predicting CPIs and binding affinities, identifying key atoms and
residues, enhancing model interpretability.


Zhili Zhao, Tongfeng Li, Yunwu Liu and Jun Ma contributed
equally to this work.




- Jun Ma

maj19@lzu.edu.com


- Ruisheng Zhang
zhangrs@lzu.edu.cn


Zhili Zhao

zhaozhl@lzu.edu.cn


Tongfeng Li
litf19@lzu.edu.cn


Yunwu Liu

liuyw19@lzu.edu.cn


Jun Ma

junma@lzu.edu.cn



1 School of Information Science and Engineering, Lanzhou
University, Lanzhou 730000, China


2 School of Information Engineering, Lanzhou University
of Finance and Economics, Lanzhou 730020, China


3 Computer College, Qinghai Normal University,
Xi‚Äôning 810016, China


Vol.:(0123456789)


362 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377


**Graphical abstract**


**Keywords** CPI prediction ¬∑ Deep learning ¬∑ Molecular graph ¬∑ Attention mechanism



**1 Introduction**


Predicting compound‚Äìprotein interactions (CPIs) is a pivotal stage in drug discovery. It plays a crucial role in drug
hit identification, lead discovery, comprehension of drug
side effects, drug repositioning, polypharmacology, drug
resistance, and other facets [1‚Äì3]. Accurate prediction of
CPIs or drug‚Äìprotein-binding affinity can significantly
accelerate lead compound generation and optimization,
facilitating the screening of potential candidate compounds [4].
The explosive growth of compound activity and biomedical data has brought new challenges to the field of
CPI prediction. Although classical virtual screening (VS)

[5 6].
] is beneficial, it does not accelerate CPI prediction [
Standard high-throughput screening (HTS) [7] experimental methods enable rapid automated testing of thousands
to millions of molecular samples. However, there are
still limitations on the time and cost for screening large
libraries [8‚Äì10]. Advances in processing speed and storage capacity of computing devices have made big data
analysis possible, driving the rapid development of artificial intelligence and machine learning technologies [11].
Machine learning techniques have been widely utilized in
drug discovery to predict interactions using large amounts
of high-dimensional complex data. These techniques offer



more promising lead candidates for experimental validation and thus reducing both time and cost [4].
In recent years, deep learning methods have triggered
unprecedented advancements in many fields, such as computer vision [12], speech recognition [13], machine translation [14], and recommended systems [15]. Moreover,
these methods have demonstrated impressive predictive
capabilities in addressing computational biology problems

[16
]. Similar to traditional machine learning, the effectiveness of deep learning is influenced by the selected features.
However, machine learning heavily relies on high-quality
features manually extracted by domain experts. In contrast,
deep learning models can automatically identify multi
dimensional low-level hidden features from structured

data. Compounds and proteins can be considered structural
data, which make them particularly suitable for processing
by deep learning models.
Many methods for CPI prediction or drug-targetrelated studies are derived from natural language processing (NLP) [6]. Small molecule compounds, typically
represented as SMILES strings [17], and proteins, often
depicted in FASTA format [18], are naturally viewed as
one-dimensional sequences with rich semantics. Consequently, various sequence-based models, including recurrent neural network (RNN) [19], long short-term memory
(LSTM) [20], 1D convolutional neural network (1D CNN)


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 363




[21], Transformer [22], and their respective variations,
have been employed to identify recurring patterns in a
given sequence.
DeepDTA [23] consisted of two independent 1D CNN
blocks that learned representations from SMILES strings
and protein sequences, and computed the final output
through a fully connected layer. This methodology has demonstrated promising potential for enhancing the predictive
accuracy of CPIs. DeepCPI [24] employed latent semantic analysis and Word2Vec techniques to learn low-dimensional feature representations of compounds and proteins
from large corpora of compounds and proteins. The model
emphasized the extraction of comprehensive and meaningful
features from complex molecular and protein structures, thus
contributing to more accurate CPI prediction. DeepAffinity [25] leveraged RNNs and 1D CNNs to jointly encode
molecular representations and obtained long-term, nonlinear
dependencies between atoms and residues in compounds and
proteins. It achieved significant advancements in CPI prediction. TransformerCPI [26] applied 1D CNN layers to encode
protein sequences and utilized word embedding methods for
encoding small molecule compounds. The model integrated
an attention mechanism to highlight important interaction
regions between protein sequences and compound atoms,
which was a significant step forward in modeling the intricate relationship between compounds and proteins. DeepLSTM [27] extracted protein evolutionary features by position specific scoring matrix (PSSM) and Legendre moment
(LM), correlating them with drug molecular substructure
fingerprints to create a drug‚Äìtarget pair feature vector.
Experimental results have demonstrated great advantages
on feature expression and recognition.
Although sequence representation is simple and convenient, one-dimensional notations are inadequate for representing molecular topology. Two similar chemical structures
may be represented by vastly different one-dimensional
symbols, and even the same compound can be represented
by different one-dimensional sequences. Consequently, critical information about compound and protein structures is
lost, which impairs the predictive power of the model and
hinders learning about functional relevance of the latent
space [28, 29].
Graph neural networks (GNNs) are designed specifically
to process graph structures and can simultaneously learn
the strength of connections between different nodes. The
effectiveness of GNN in predicting CPIs has been widely
acknowledged due to its representation learning capability.
Molecular graphs are used to represent small molecule compounds, where atoms and chemical bonds serve as nodes and
edges, respectively. Similarly, proteins can be depicted as
structural graphs, with nodes representing atoms or amino
acids and edges representing their neighborhood relationships. Various graph-based neural networks, including



graph convolutional network (GCN) [30] and their variants,
are commonly used for automatic feature representation
of compounds and proteins. These models effectively capture essential CPI information by embedding neighboring
node features into the central node when learning feature
representations.
GraphDTA [29] represented drugs as molecular graphs
using four GNN variants (i.e., GCN, graph attention network (GAT), graph isomorphic network (GIN) and combined GAT-GCN), respectively. Protein features was
obtained using a multilayer 1D CNN. The results showed
that GNNs not only predict drug-target affinity better than
non-deep learning models, but also outperform competing
deep learning methods. CPI-CNN [31] employed GNNs
with r-radius subgraphs and CNN to learn low-dimensional
vector representations of molecular graphs and protein
sequences, respectively. The approach achieved competitive performance with significant advantages especially on
unbalanced datasets. Graph-CNN [32] employed two graph
autoencoders, one for modeling molecular graph structures
and the other for representing protein pockets. This approach
enabled the extraction of features from both pocket graphs
and 2D ligand graphs. Notably, Graph-CNN demonstrated
its ability to accurately capture protein‚Äìligand-binding
interactions without relying on target-ligand complexes.
Recently, DGraphDTA [33] utilized the structural information of compounds and proteins to construct molecule graphs
and protein contact maps, respectively. By connecting these
representations, DGraphDTA achieved reliable affinity prediction and exhibited robustness and generalizability when

tested on benchmark datasets.

Currently, Transformer has demonstrated remarkable
capabilities in feature learning. Its success mainly attributed to its attention mechanism, which allows it to capture
implicit semantic correlations. These correlations represent association of semantic information between tokens,
such as words, phrases, and other linguistic units, and are
measured by the possibility of their co-occurrence in the
context. In fact, the advantage of the attention mechanism
can be extended from sequences to molecules. Essentially,
any compound or protein can be regarded as a sequence of
nodes with a specific order and spatial arrangement. If these
sequences are considered as sentences, then the nodes are the

tokens that form the sentence. Just like the semantic correla
tions between tokens, there inevitably exists a similar semantic correlation between nodes. In this context, the attention
mechanism describes how nodes in molecular sequences are

related to each other based on their node attributes.

For example, in the case of compounds, carbon (C)
atoms generally tend to form multiple covalent bonds
with C, hydrogen (H), oxygen (O), and nitrogen (N)
atoms, which indicates that C atoms are semantically more
related to them than to other atoms. As determined by the


364 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377



properties of the atoms themselves, the similarity between
C and C atoms is higher than that between C and S atoms.
Therefore, after the attention mechanism learning, when
the atoms are projected to the word vector space, the dis
tance between C and C atoms is closer than that between

C and sulfur (S) atoms, indicating that the semantic correlation between the former is stronger. Similarly, there are
also semantic correlations among amino acids. This prevalent semantic correlation reflect the importance of nodes
in the sequence. Transformers can capture these correlations to generate feature vectors, also known as semantic
features, that describe the semantic information of nodes.
However, it is insufficient to rely solely on the semantic information of nodes in molecules for predicting CPI,
which would ignore important structural features. Structural features of compounds and proteins include but are
not limited to adjacencies, distances, and angles between
nodes. To some extent, most GCN-based CPI methods
exploit the adjacency of nodes within a molecule to aggregate features but neglect the semantic features of nodes.
The objective of this study is to develop an interpretable model, termed Graph Transformer CPI (GraphsformerCPI), which integrates the semantic and structural
features of compounds and proteins for CPI prediction.
Inspired by attention mechanisms and graph convolutional networks, we extend the application of attention
mechanisms from sequences to molecules to deepen our
understanding of the complex relationship between compounds and proteins and improve the accuracy of CPI
prediction. To overcome the limitation of using only a
single sequence or graph representation, this research
aims to effectively encode the topological structure
of molecules and capture the semantic correlations
between nodes to bridging the gap between these two
representations. By combining the strengths of attention
mechanisms and the graph structural information, our
GraphsformerCPI model offers a promising approach to
predicting CPIs.

The main contributions of this research are summarized

as follows:


- We present a novel framework that integrates attention
mechanisms and structural features of molecular graphs
to predict CPI by effectively combining the one-dimensional sequences and two-dimensional structures of compounds and proteins.

- The proposed model focuses on the relationship features
between compounds and proteins, and utilizes a dual
attention mechanism to achieve sufficient fusion of their
node features.

- Utilizing structure-enhanced attention mechanism can
improve the CPI prediction performance and provide the



model with good interpretability, which is not possessed
by many black-box deep learning models.


**2 Materials and Methods**


**2.1 GraphsformerCPI Overview**


The overall architecture of GraphsformerCPI is illustrated in Fig. 1. The model is a stack of multiple identical encoder‚Äìdecoder layers, with each layer comprising
two encoders and one decoder. The encoders employ selfattention mechanisms to autonomously learn the semantic features of compounds and proteins. Subsequently,
these acquired semantic features are integrated with
their respective graph features to establish comprehensive representations. The decoder computes the affinity
probabilities between different tokens of compound atoms
and protein residues, thereby identifying the global attention between atoms and residues. Ultimately, a predefined
predictor is used to determine the relationship between
compounds and proteins.


**2.2 Structure‚ÄëEnhanced Encoder**


The native Transformer encoder serves as a module for processing sequential data, exhibiting remarkable performance
in calculating the semantic similarity among internal nodes
within a sequence. This capability is equally valuable in the
study of compounds and proteins. However, compounds and
proteins possess intricate spatial structural features that are
vital for comprehending their function, properties, and interactions. In order to enable the encoder to capture structural
features, we have improved the original encoder.

The structure-enhanced encoder consists of a multi-head

self-attention mechanism (MHA) sub-layer and a positionwise feed-forward network (FFN) sub-layer. In the selfattention mechanism, symmetrically normalized Laplacian
matrices and Euclidean distance are employed to capture
spatial attention between nodes, as shown in Fig. 2. This
enhancement enable comprehensive consideration of semantic and spatial structural features of compounds and proteins,
thereby augmenting the model‚Äôs understanding and predictive capabilities regarding their function and properties.
The Laplacian matrix plays a role similar to that in
GCN. The average aggregation method assigns appropriate
weights to nodes, where nodes with higher degrees transmit
less information to each edge to prevent excessive influence on neighboring nodes. Euclidean distance is one of the
important features in describing the molecular structure of
compounds and proteins. Changes in the distance between
nodes significantly impact the molecule‚Äôs properties. In general, when the Euclidean distance between _C_ _ÌõΩ_ atoms is less


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 365


Encoder-Decoder layers √ó















_H_ p













:Softmax Ôºã :Skip-connect √ó :Matrix multiplication



**Fig. 1** Schematic overview of the _l_ th encoder‚Äìdecoder sub-layer in
GraphsformerCPI. The GraphsformerCPI model is composed of _N_
identical layers, each consisting of two encoders and one decoder.
The hidden features _H_ c _[l]_ [‚àí][1] [ and ] _[H]_ p _[l]_ [‚àí][1] [ of the compounds and proteins ]
learned in the previous layer are used as inputs to the current layer.
The compound encoder learns structure-enhanced deep features of
compounds by modeling and encoding different compound atoms
using self-attention mechanism. Similarly, the protein encoder learns
structure-enhanced deep features of the proteins by modeling and
encoding residue information. The dual-attention decoder combines
the features learned by the encoders to extract interactions between


than 8 _A_ _[Ãä]_, it indicates that there is an interaction between two

residues. The strength of this interaction increases as the
distance between residues decreases, and vice versa.
To simplify the description of the relationship between
interaction strength and Euclidean distance, we use the
exponential function _e_ [‚àí] _[x]_ to transform the distance. This
transformation projects smaller distances to larger interaction strengths, thus providing a more accurate depiction of

interactions within molecular structures.
More specifically, let us consider compounds as an example. Assume that any compound consists of _N_ atoms, the
model performs _h_ times attention function in parallel, _Q_ _i_,
_K_ _i_ ‚àà ‚Ñù _[N]_ [√ó] _[d]_ _[K]_, and _V_ _i_ ‚àà ‚Ñù _[N]_ [√ó] _[d]_ _[V]_ are the projection matrices for
the _i_ th head, respectively, and _d_ is the dimension of the feature vector. The symmetric normalized Laplacian matrix for
the compound is denoted as _L_ _sym_ ‚àà ‚Ñù _[N]_ [√ó] _[N]_, and the Euclidean distance matrix is represented as _Dist_ ‚àà ‚Ñù _[N]_ [√ó] _[N]_ . The formulation of the multi-head self-attention sub-layer in the

enhanced encoder is as follows:


_Q_ _i_ = _QW_ _i_ _[Q]_ [,] _K_ _i_ = _KW_ _i_ _[K]_ [,] _V_ _i_ = _VW_ _i_ _[V]_ (1)



compound atoms and protein residues. This affinity probability is
extracted through a inter-attention mechanism. Finally, the learned
relational features of the decoder are skip-connected with the output
features of the encoder, generating the output _H_ c _[l]_ [ and ] _[H]_ p _[l]_ [ of the layer. ]

Hence, the GraphsformerCPI model can progressively learn complex
features of compound‚Äìprotein interactions layer by layer. Notes that
_A_ denotes the space of inter-attention between compound atoms and
protein residues, _m_ represents the number of atoms in the compound,
_n_ represents the number of residues in the protein, and _d_ represents
the dimension of the feature vectors



_MHA_ = [ _Attn_ ( _V_ 1 ), ..., _Attn_ ( _V_ _h_ )] _W_ _[o]_ (5)


_O_ _MHA_ = _Q_ + _MHA_ (6)


where the projections are parameter matrices _W_ _i_ _[Q]_ [, ]
_W_ _i_ _[K]_ [‚àà] [‚Ñù] _[d]_ [√ó] _[d]_ _[K]_ [, ] _[W]_ _i_ _[V]_ [‚àà] [‚Ñù] _[d]_ [√ó] _[d]_ _[V]_ [, ] _[W]_ [(][1] _[‚ãÜ]_ [1][)] [ ‚àà] [‚Ñù] [3][√ó][1] [ and ] _[W]_ _[O]_ [ ‚àà] [‚Ñù] _[hd]_ _[v]_ [√ó] _[d]_ [, ]
and [, ] represents the concatenation. We calculate elementwise _f_ ( _x_ ) = _exp_ (‚àí _x_ ) on the distance matrix.
Utilizing the input node features, the encoders compute semantic weights between nodes through a multi-head
self-attention mechanism, generating a weight matrix that
reflects the similarity of node features. The normalized
semantic weight matrix, as illustrated in Eq. 2, is obtained



_A_ ( _Q_ _i_, _K_ _i_ ) = _stack_ ( _softmax_ ( _Q_ _i_ _K_ _i_ _[T]_ ), _L_ _sym_, _f_ ( _Dist_ )) (2)



_i_
~~‚àö~~ _d_ _K_



_d_ _K_



), _L_ _sym_, _f_ ( _Dist_ ))



_AÃÇ_ ( _Q_ _i_, _K_ _i_ ) = _A_ ( _Q_ _i_, _K_ _i_ ) _W_ [(][1] _[‚ãÜ]_ [1][)] (3)


_Attn_ ( _V_ _i_ ) = _A_ _[ÃÇ]_ ( _Q_ _i_, _K_ _i_ ) _V_ _i_ (4)


366 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377


**2.3 Dual Attention Decoder**







Merely connecting the hidden features of compounds and
proteins obtained by the encoder is insufficient for accurately
predicting their interactions. This approach overlooks the
essential relational features between compounds and proteins, which are crucial for comprehending their interactions.
To overcome this limitation, we propose a decoder with dual

attention.

The decoder leverages attention mechanisms to construct
feature spaces for compound atoms and protein residues.
By individually projecting compound atoms and protein
residues into these feature spaces, we establish their inter
attention. This attention reveals the intrinsic relationship
between compound atoms and protein residues, enhancing
the capacity of compounds and proteins to recognize each
other. Through this dual attention mechanism, we achieve
more accurate predictions of compound‚Äìprotein interactions.
Let _X_ _C_ = [ _c_ _[T]_ 0 [,] _[ c]_ 1 _[T]_ [, ...,] _[ c]_ _[T]_ _N_ ‚àí1 []] _[T]_ [ ‚àà] [‚Ñù] _[N]_ [√ó] _[d]_ [ denote a sequence ]
of compound vectors and _X_ _P_ = [ _p_ _[T]_ 0 [,] _[ p]_ 1 _[T]_ [, ...,] _[ p]_ _[T]_ _M_ ‚àí1 []] _[T]_ [ ‚àà] [‚Ñù] _[M]_ [√ó] _[d]_
denote a sequence of protein vectors generated by the _l_ -th
layer encoder, where _N_ and _M_ represent the number of atoms
in the compound and the number of residues in the protein,
respectively. Here, _c_ _[T]_ _i_ [‚àà] [‚Ñù] [1][√ó] _[d]_ [ and ] _[p]_ _[T]_ _i_ [‚àà] [‚Ñù] [1][√ó] _[d]_ [ represent the ]
atomic features and the residue features, both possessing

the same dimension _d_
. The dual affine transformation of the
decoder at the _l_ th layer can be expressed as follows:









































Node feature


**Fig. 2** Schematic overview of the multi-head attention (MHA) sublayer of the GraphsformerCPI


by applying a _softmax_ function and then stacked with the
Laplacian matrix and the Euclidean distance matrix to
form a three-dimensional feature weight matrix denotes
as _A_ ( _Q_ _i_, _K_ _i_ ) . Each channel within this weight matrix is an
independent feature space that captures the correlation of
nodes in different spaces.
Since it is difficult to directly project node features into
this high-dimensional feature space, a 1 √ó 1 convolution
operation is employed to fuse the weights by channel, as
shown in Eq. 3. This operation reduces the dimension of
the _A_ ( _Q_ _i_, _K_ _i_ ) matrix and introduces nonlinear transformations to generate a composite feature space denoted as

_AÃÇ_ ( _Q_ _i_, _K_ _i_ ) .
Finally, as depicted in Eq. 6, the feature vectors are
skip-connected with the original node feature vectors.
It is important to note that the normalization process is
not explicitly mentioned in the above equations. In practice, they are incorporated at the outset of the _MHA_ and
_FFN_, as depicted in Fig. 2, to improve the performance of
GraphsformerCPI.



_A_ ( _X_ _C_, _X_ _P_ ) = _softmax_ ( _X_ _C_ _X_ _P_ _[T]_ ) (7)



_P_
~~‚àö~~ _d_ ‚àï _h_



)



_d_ ‚àï _h_



_Attn_ ( _X_ _C_ ) = _A_ ( _X_ _C_, _X_ _P_ ) _X_ _P_ (8)


_Attn_ ( _X_ _P_ ) = _A_ ( _X_ _P_, _X_ _C_ ) _X_ _C_ (9)


_H_ _C_ _[l]_ [=] _[ X]_ _[C]_ [ +] _[ Attn]_ [(] _[X]_ _[C]_ [)] (10)


_H_ _P_ _[l]_ [=] _[ X]_ _[P]_ [ +] _[ Attn]_ [(] _[X]_ _[P]_ [)] (11)


In Eq. 7, an attention space is created between atoms and
residues. The dual attention decoder assigns different
weights to various parts of the compound and protein. In
Eq. 8, the protein feature sequences are projected into the
attention space _A_, with greater attention given to the parts
of the compound that have a stronger impact on binding.
Similarly, in Eq. 9, the compound features are projected into
the dual space of _A_, highlighting the parts of the proteins that
have significant effects.
The dual attention decoder project node-level features
of compounds and proteins into each other‚Äôs feature space,
respectively. This enables us to model compound‚Äìprotein


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 367



relationships and capture depth features related to the interaction, rather than representing such interactions through simple
feature concatenation or summation. Additionally, skip connections are employed in the dual attention decoder to fuse
learned relationship features with the hidden node features to
prevent model overfitting and gradient vanishing, as shown in
Eqs. 10 and 11.


**2.4 Prediction module**


Assuming that the embedding features of compounds and proteins generated by the last encoder‚Äìdecoder layer are denoted
as _H_ _C_ ‚àà ‚Ñù _[N]_ [√ó] _[d]_ and _H_ _P_ ‚àà ‚Ñù _[M]_ [√ó] _[d]_, respectively, where _N_ represents the number of atoms in the compound, _M_ represents the
number of residues in the protein, and _d_ represents the dimension of the embedding space.
The predictor calculates the node weights for compound
atoms and protein residues, and then derives the graph-level
feature vectors of compounds and proteins through weighted
summation. Specifically, for the node weights of compound
atoms, the calculation formula is:


_Ìõº_ _i_ _[C]_ [=] _[ Ìúé]_ [(] _[h]_ _[C]_ _i_ _[W]_ _[C]_ [)] (12)


Here, _h_ _[C]_ _i_ [ represents the embedding feature of the ] _[i]_ [-th atom ]
in the compound, _W_ _[C]_ ‚àà ‚Ñù _[d]_ [√ó][1] is learnable parameter, and _Ìúé_ (‚ãÖ)
represents the activation function. Similarly, for the node
weights of protein residues, the calculation formula is:


_Ìõº_ _[P]_
_j_ [=] _[ Ìúé]_ [(] _[h]_ _[P]_ _j_ _[W]_ _[P]_ [)] (13)


Here, _h_ _[P]_ _j_ [ represents the embedding feature of the ] _[j]_ [-th residue ]
in the protein, _W_ _[P]_ ‚àà ‚Ñù _[d]_ [√ó][1] is learnable parameter.
The graph-level feature vectors for compounds and proteins

are calculated as follows:



result, which is transformed into probability via the _softmax_

function.
In the case of a classification task, GraphsformerCPI
employs cross-entropy loss as its objective function and
minimizes it in the following way:



_L_ = [1] ‚àë ‚àí[ _y_ _i_ log( _yÃÇ_ _i_ ) + (1 ‚àí _y_ _i_ ) log(1 ‚àí _yÃÇ_ _i_ )] (17)



_N_



_N_
‚àë



_i_



‚àí[ _y_ _i_ log( _yÃÇ_ _i_ ) + (1 ‚àí _y_ _i_ ) log(1 ‚àí _yÃÇ_ _i_ )]



Where _y_ _i_ ‚àà{0, 1} denotes the label and _N_ represents the
number of samples.
In the case of a regression task, the model employs mean
squared error (MSE) as its objective function and minimizes
it in the following manner:



_L_ = [1] ‚àë( _y_ _i_ ‚àí _yÃÇ_ _i_ ) [2] (18)



_N_



_N_
‚àë



_i_



( _y_ _i_ ‚àí _yÃÇ_ _i_ ) [2]



_N_
‚àë

_i_ =1



_Ìõº_ _i_ _[C]_ _[h]_ _[C]_ _i_



_v_ _C_ = _Ìõº_ _[h]_ (14)



_i_



_M_
‚àë



_Ìõº_ _j_ _[P]_ _[h]_ _[P]_ _j_



_j_



_v_ _P_ = _Ìõº_ _j_ _[h]_ _j_ (15)

_j_ =1


Here, _v_ _C_ ‚àà ‚Ñù _[d]_ and _v_ _P_ ‚àà ‚Ñù _[d]_ represent the graph-level feature
vectors for compounds and proteins, respectively.
Finally, to predict the relationship between compounds and
proteins, we concatenate these two feature vectors and utilize
a fully connected layer for prediction:


_yÃÇ_ = softmax([ _v_ _C_, _v_ _P_ ] _W_ _O_ ) (16)


Here, _W_ _O_ ‚àà ‚Ñù [2] _[d]_ [√ó(][2] _[or]_ [1][)] is learnable parameter, [ _v_ _C_, _v_ _P_ ] represents the concatenation of the feature vectors for compounds and proteins, and _yÃÇ_ represents the final prediction



**2.5 Feature Representation**


**2.5.1 Compound Representation**


In GraphsformerCPI, compounds are initially described
by SMILES strings. We parse compound descriptors from

SMILES and extract their raw features as vectors that can be

processed by the encoder.
Specifically, the compound SMILES dataset is analogized
to a ‚Äúcorpus‚Äù consisting of ‚Äúsentences‚Äù (in this case, atoms)
of varying lengths. We tokenize the compounds based on
atoms, truncating compounds longer than a predefined
length and padding compounds shorter than the predefined
length. We encode the attributes of the atoms using onehot encoding, obtaining 78-dimensional raw features of the
compound X _C_ ‚àà ‚Ñù _[N]_ [√ó][78] . The selected atom attributes in this
study are the same as those in GraphDTA and are listed in

Table 1.

To incorporate spatial information, we construct molecular
graphs with atoms as nodes and chemical bonds as edges. We
utilize the RDKit [34] Python package to retrieve atomic attributes and spatial three-dimensional coordinates based on the


**Table 1** The details of atom features


No Feature Description Dimension


1 Atom symbol One hot encoding of the atom type 44

2 Atom degree The number of directly-bonded 11
neighbors


3 Total Hs The number of total Hs on the atom 11

4 Implicit Hs The number of implicit Hs on the 11

atom


5 Aromatic Whether the atom is aromatic 1


368 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377



adjacency relationship of nodes in the molecular graph. Subsequently, we calculate the Euclidean distance between atoms
to capture molecular structure information. Each element of
the Euclidean distance matrix is subjected to computation of
the negative exponential power with base _e_, as described in
Sect. 2.2. To account for the impact of structural features on
nodes, we employ a symmetric normalized Laplacian matrix
with self-loops in graph construction, similar to GCN. The formula for the normalized Laplacian is shown below:



human proteome and 20 other major organisms. The PDB files
of proteins are downloaded, residue information is parsed, and
Euclidean distance matrices and contact maps are constructed
to represent structural information.
Suppose the protein sequence has a length of _L_, the predicted contact map _M_ and Euclidean distance matrix _Dist_

both have _L_ rows and _L_ columns. The elements of the contact

map matrix, _M_ _ij_, indicate whether the corresponding residue
pair ( _i_, _j_ ) is in contact. The elements of the Euclidean distance
matrix, _Dist_ _ij_, represent the Euclidean distance between the
corresponding residue pairs, as follows:



_L_ _sym_ = _D_ _[ÃÉ]_ [‚àí] 2 [1]




[1]

2 _A_ _[ÃÉ]_ _D_ _[ÃÉ]_ [‚àí] [1] 2



2



where _A_ _[ÃÉ]_ is the adjacency matrix with self-loops, and _D_ _[ÃÉ]_ is the
degree matrix with respect to _A_ _[ÃÉ]_ .


**2.5.2 Protein Representation**


Protein representation primarily involves generating residue
identity descriptors and spatial structure features. By treating residues as nodes rather than atoms, we can effectively
mitigate the computational challenges posed by excessive data.
Similar to compound representation, the first step is to obtain
protein graphs, also known as contact maps, which indirectly
represent three-dimensional structural features with a twodimensional residue matrix. Therefore, acquiring highly reliable protein structure data is essential.
Due to the limited number of known protein structures,
many protein structures remain undetermined. Therefore, it
is not always feasible to obtain reliable tertiary structures and
there are obstacles to directly using existing protein structure
data. We utilized the protein structures predicted by AlphaFold2 [35
]. AlphaFold2 has achieved significant advancements
in protein structure prediction, contributing to more accurate
and efficient prediction of CPI. The AlphaFold database
[(https://‚Äãalpha‚Äãfold.‚Äãebi.‚Äãac.‚Äãuk/) provides protein structures for the](https://alphafold.ebi.ac.uk/)



where _Ìõø_ denotes the Euclidean distance between the _C_
_ij_ _ÌõΩ_
atoms of residues _i_ and _j_ . Residues are considered to be in
contact if _ùõø_ _ij_ _<_ 8 _A_ _[Ãä]_ . It is worth noting that both the distance
matrix and contact map are non-negative, symmetric square
matrices. The diagonal elements of the distance matrix are
0, while those of the contact map are 1.
After obtaining the Euclidean distance matrix and contact
map, GraphsformerCPI extracts the physicochemical prop
erties of amino acids as node features for residues. These

properties are determined by the side chain R-groups of
amino acids, including polarity, electrification, aromaticity,
hydrophobicity, and more. To simplify their representation,
we adopt the amino acid properties documented in previous
literature [33, 36]. These selected properties are encoded
using the one-hot mechanism and concatenated into a protein feature matrix X _P_ ‚àà ‚Ñù _[L]_ [√ó][50], where _L_ denotes the length
of the protein sequence. Detailed features of residues are

listed in Table 2.



_Dist_ _ij_ =



_ùõø_ _ij_ if _i_ ‚â† _j_,
0 otherwise.
{



1 if _ùõø_ _ij_ _<_ 8 _A_ _[Ãä]_,
0 otherwise.



_M_ _ij_ =



{



**Table 2** Details of residue
No Feature Description Dimension
features


1 Residue symbol One-hot encoding of the residue symbol 21

2 Aliphatic Aliphatic residue or not 1

3 Aromatic Aromatic residue or not 1

4 Polar neutral Whether it is a polar neutral residue 1

5 Polar positive charge Whether it is a polar positive charge residue 1

6 Polar negative charge Whether it is a polar negative charge residue 1

7 Molecular weight Molecular weight of amino acids 1

8 pK _a_ Negative log of the dissociation constant of ‚ÄìCOOH group 1

9 pK _b_ Negative log of the dissociation constant of ‚ÄìNH 3 group 1

10 pK _x_ Negative log of the dissociation constants of other groups 1

11 pl Isoelectric point 1

12 Hydrophobicity-1 Hydrophobicity of residue at pH 2 1

13 Hydrophobicity-2 Hydrophobicity of residue at pH 7 1

14 Meiler Meiler feature 7

15 Kidera Kidera feature 10


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 369



**2.6 Datasets**


The performance of the proposed GraphsformerCPI model
is evaluated using four CPI datasets: human, _C. elegans_ [31],
Davis [37] and KIBA [38]. These datasets are commonly
used as benchmark datasets for evaluating binding affinity
prediction [23, 26, 29, 33, 39].
The human and _C. elegans_ datasets are employed to
assess the classification performance of the model. These
datasets were created by Liu et al. [40]. The positive samples
came from DrugBank 4.1 [41], Matador [42], and STITCH
4.0 [43
]. To ensure high-confidence negative samples of
compound-protein pairs, various compound and protein
resources were integrated into a systematic screening framework. The prediction task is to determine whether a given
compound and protein pair interact. The model predicts a
binary label indicating interaction (1) or no interaction (0)
between the compound and protein. To ensure a fairness in
the comparison, a balanced dataset is used following the
protocol described in reference [31]. The positive to negative sample ratio is maintained at 1:1. The balanced human
dataset consists of 3369 positive interactions involving 1052
unique compounds and 852 unique proteins. The balanced
_C. elegans_ dataset comprises 4000 positive interactions with
1434 unique compounds and 2504 unique proteins.

The Davis and KIBA datasets are used to evaluate the

regression performance of the proposed model. The Davis
dataset, collected from clinical trials of kinase protein families and related inhibitors [37], includes 442 proteins, 68
compounds, and binding affinity values (dissociation constants, (K d )) for protein‚Äìcompound pairs [44]. The K d values
in the Davis dataset are transformed into logspace (pK d )
using the following formula:



**3 Results and Discussion**


**3.1 Evaluation Metrics**


Several evaluation metrics commonly used in the benchmark
evaluation are employed in this study, including Concordance index (CI) [45], MSE, and Pearson correlation coefficient [46] for regression performance, as well as the area
under the receiver operating characteristic curve (AUC),
precision, and recall for classification performance.
The CI measures the extent to which the predicted CPI
affinity values are ordered in a manner consistent with the
true values, and it is calculated using the following formula:



_CI_ = [1]

_Z_



‚àë

_ùõø_ _i_ _>ùõø_ _j_



_h_ ( _p_ _i_ ‚àí _p_ _j_ )



where _p_ _i_ represents the predicted value of the larger affinity
_Ìõø_ _i_, _p_ _j_ represents the predicted value of the smaller affinity
_Ìõø_ _j_, and _Z_ is a normalization constant. The step function _h_ ( _x_ )
is defined as:



_h_ ( _x_ ) =



‚éß
‚é™
‚é®
‚é™‚é©



1 if _x >_ 0

0.5 if _x_ = 0

0 if _x <_ 0



)



_pK_ d = ‚àí log 10



_K_ d
( 10 [9]



The KIBA dataset was generated from several sources of
kinase inhibitor bioactivities [38
]. Different bioactivities,
such as K _i_, K d and IC 50, were integrated by a method called
KIBA. The dataset initially contained 467 targets, 52,498
44], the
drugs and 246,088 observations. After filtering by [
dataset consists 229 unique targets, 2111 unique drugs and
118,254 target‚Äìdrug-binding affinities measured by KIBA
values.

When evaluating the model performance, the human and
_C. elegans_ datasets are randomly shuffled and divided into
six parts. One part is used as the test set, while the remaining
portions serve as training and validation sets for five-fold
cross-validation. For the Davis and KIBA datasets, all five
training and test sets are utilized following the methodology
described in reference [33].



MSE is a widely used measure of the disparity between predicted values and true values. A smaller mean square error
indicates that the predicted values closely align with the true
values. The formula for MSE is described by Eq. 18.
The Pearson correlation coefficient ( _r_ ) is employed to
quantify the linear relationship between a predicted value
dataset and a true value dataset. A positive correlation
implies that an increase in variable _x_ corresponds to a corresponding increase in variable _y_, while a negative correlation suggests that an increase in _x_ leads to a decrease in _y_ .
The Pearson correlation coefficient is given by:



where _xÃÑ_ denotes the mean of the vector _x_ _i_ and _yÃÑ_ denotes the
mean of the vector _y_ _i_ .
AUC is a critical metric for evaluating classifier performance and measures the overall performance of the classifier. It is calculated by plotting the true positive rate (TPR)
against the false positive rate (FPR) at various classification
thresholds. AUC values ranges between 0 and 1, with values
closer to 1 indicating superior classifier performance.
Precision measures the proportion with which the model
can correctly identify positive interactions (True Positive)
among all predicted positive interactions. A higher Precision



_r_ =



_N_
‚àë _i_ [(] _[x]_ _[i]_ [‚àí] _[x][ÃÑ]_ [)(] _[y]_ _[i]_ [‚àí] _[y][ÃÑ]_ [)]

~~ÔøΩ‚àë~~ _Ni_ [(] _[x]_ _[i]_ [ ‚àí] _[x][ÃÑ]_ [)] [2] ~~[‚àë]~~ _[N]_ _i_ [(] _[y]_ _[i]_ [ ‚àí] _[y][ÃÑ]_ [)] [2]


370 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377



**Table 3** The hyperparameter settings


Hyper-parameter Setting


Epoch (classification) 500
Epoch (regression) 2000
Batch size (classification) 32
Batch size (regression) 64

Optimizer Adam

Learning rate 0.001


score indicates that the model can more accurately identify
positive interactions, reducing false positive predictions and
increasing prediction reliability.
Recall measures the completeness with which the model
can detect True Positive interactions among all interactions
present in the validation dataset. A higher Recall score indicates that the model is better able to detect true positive
interactions, reducing false negative predictions and enhancing model sensitivity.


**3.2 Hyperparameter Settings**


Setting and optimizing hyperparameters is a crucial and
time-consuming aspect of training deep learning model.
GraphsformerCPI utilizes a five-fold cross-validation strategy, and the model encompasses several pivotal parameters that require meticulous selection. While some of these
parameters are designated empirically, others are established
by referencing existing models. The ranges of hyperparam
eters utilized are detailed in Table 3.


**3.3 Impact of Model Depth**


The foundational architecture and the depth of the model
are key factors influencing prediction performance. Here,
we explore the impact of varying the number of layers
on the performance of GraphsformerCPI. It is important
to note that simply increasing the number of layers does



not guarantee improved performance. On the contrary, an
excessive number of layers can lead to memory overflow and
strain the computational capabilities of the device.
In our model, the number of layers is varied between 2
and 4. As shown in Table 4, GraphsformerCPI consistently
demonstrates high classification performance when utilizing 2‚Äì4 layers, yielding average values exceeding 0.9 for
all three metrics. Notably, setting the number of layers to
4 yields the most favorable outcomes, with AUC and recall
rates of 0.990 and 0.979, respectively, on the human dataset, and AUC and recall rates of 0.989 and 0.959, respectively, on the _C. elegans_ dataset. Furthermore, as illustrated
in Table 5, the model also demonstrates satisfactory performance on the regression dataset, with an improvement
in performance metrics such as MSE, Pearson correlation
coefficient, and CI index as the number of layers increases
to four.

It is apparent that increasing the number of layers in
GraphsformerCPI enhances the model‚Äôs performance. By
incorporating more encoders, the model comprehensively
and diversely learns compound and protein self-features,
capturing deep features at the node-level for compounds
and proteins. Moreover, an increasing the number of layers facilitates deeper interactions between compound and
protein node-level features. These enriched features with
diverse emphases are extensively fused through multi-layer
interactions, improving the likelihood of accurately predicting compound‚Äìprotein affinities.
4,
However, there exists a trade-off. As observed in Table
a slight decrease in accuracy with an increase in the number
of layers implies a potential for overfitting on small datasets.
Therefore, a balance must be struck between the model‚Äôs
performance and the number of layers employed.


**3.4 Impact of Dropout Rate**


Figures 3 and 4 illustrate the impact of different dropout
rates on the performance of GraphsformerCPI on different



**Table 4** Performance of various

module layers on the human and
_C. elegans_ datasets


**Table 5** Performance of various

module layers on the Davis and
KIBA datasets



Human _C. elegans_


No. of layers AUC‚Äã Precision Recall No. of layers AUC‚Äã Precision Recall


2 0.914 0.890 0.942 2 0.936 0.936 0.933

3 0.966 0.970 0.960 3 0.947 0.948 0.942

4 0.990 0.952 0.979 4 0.989 0.935 0.959


Davis KIBA


No. of layers MSE Pearson CI No. of layers MSE Pearson CI


2 0.559 0.653 0.750 2 0.450 0.685 0.776

3 0.304 0.774 0.849 3 0.299 0.781 0.867

4 0.212 0.802 0.908 4 0.141 0.895 0.913


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 371


**Fig. 3** Performance of various dropout rates on the human and _C. elegans_ datasets


**Fig. 4** Performance of various dropout rates on the Davis and KIBA datasets


372 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377



datasets. In our experiments, we varied the dropout rates
between 0.1 and 0.4 to mitigate the risk of underfitting caused
by excessively high dropout rate. The results reveal that as the
dropout rate increases, there is a decreasing trend in AUC,
precision, and recall on the human dataset. Similarly, the _C._
_elegans_ dataset demonstrates a declining pattern in AUC,
while precision and recall exhibit fluctuations. Notably, at
a dropout rate of 0.3, precision reaches 0.959, while recall
decreases to 0.847. For the Davis and KIBA regression datasets, MSE increases with the dropout rate, whereas the Pearson correlation coefficient and CI decreased slightly.
Based on these findings, it can be concluded that the
dropout rate significantly impacts the performance of
GraphsformerCPI. Setting the dropout rate too high can
result in inferior performance. Therefore, to achieve optimal
performance, it is recommended to avoid excessively high
dropout rates. In summary, GraphsformerCPI demonstrates
optimal performance when the dropout rate is set to 0.1.


**3.5 Comparison with Other Methods**


To further evaluate the performance of our model, we conducted comparison with several classic machine learning
models, including K-nearest neighbor (KNN), Random Forest
(RF), L2-logistic (L2), and Support Vector Machine (SVM),
as well as state-of-the-art (SOTA) deep learning models such
as GCN, CPI-GNN [31], TransformerCPI [26], GraphDTA

[29], CoaDTI [39], KronRLS [47], SimBoost [44], DeepDTA

[23], WideDTA [48], and DGraphDTA [33]. In this comparison, GraphsformerCPI adopts a 4-layer structure, while TransformerCPI, GraphDTA, CoaDTI, and DGraphDTA followed
the default settings described in the literature.
Table 6 presents results on the human and Celegans
datasets. Notably, GraphsformerCPI achieves higher performance compared to the benchmark models. On the human
dataset, GraphsformerCPI achieves an AUC of 0.990,



precision of 0.952, and recall of 0.979, surpassing the classical models. Furthermore, when compared to the current
state-of-the-art models, GraphsformerCPI shows improvements of 1.6%, 0.5%, and 5.3% in terms of AUC, precision,
and recall, respectively. Similarly, on the _C. elegans_ dataset,
GraphsformerCPI exhibits improvements of 1.0% and 1.8%
in AUC and recall, respectively.
The comparison results on regression datasets are presented in Table 7. These models employ diverse algorithms
for extracting compound and protein features, such as
Smith‚ÄìWaterman (S-W), PubChem Sim, CNN, GCN, as
well as sequence-based methods including PDM and LMCS

[48]. GraphsformerCPI demonstrates competitive performance against the benchmark models on various metrics.
For instance, when evaluating on the Davis dataset, GraphsformerCPI achieves an average CI value of 0.910 with a
standard deviation of 0.013, indicating a mean increase of
2.1% in CI compared to the baseline performance. Similarly,
on the KIBA dataset, GraphsformerCPI demonstrates an
average CI value of 0.913 with a standard deviation of 0.021,
corresponding to a mean improvement of 3.3% in CI. Moreover, the MSE indicators for GraphsformerCPI on these two
datasets are 0.212 ¬± 0.019 and 0.141 ¬± 0.016, representing
mean improvements of 1.4% and 7.2%, respectively.
These results demonstrate that incorporating spatial structural information into attention mechanisms empowers the
model with strong learning capabilities, enabling it to capture not only the semantic features between nodes but also
the influence of structure on feature learning. By employing
multi-layer dual attention, the model effectively integrates
relationship features between compounds and proteins with
node features, resulting in a more comprehensive representation of affinity for CPI prediction. This approach allows the
model to learn the intricate internal and mutual information

of proteins and compounds, ultimately improving its performance compared to other deep learning models.



**Table 6** Comparison results of GraphsformerCPI and baselines on the human and _C. elegans_ datasets


Methods human _C. elegans_


AUC‚Äã Precision Recall AUC‚Äã Precision Recall


KNN 0.860 0.927 0.798 0.858 0.801 0.827

RF 0.940 0.897 0.861 0.902 0.821 0.844

L2 0.911 0.913 0.867 0.892 0.890 0.877

SVM 0.898 0.916 0.921 0.890 0.776 0.807

CPI-GNN 0.966 0.915 0.917 0.965 0.919 0.923

CoaDTI 0.970 0.948 0.930 0.978 **0** . **950** 0.942

GCN 0.932 ¬± 0.040 0.849 ¬± 0.008 0.915 ¬± 0.010 0.963 ¬± 0.005 0.918 ¬± 0.007 0.920 ¬± 0.010

GraphDTA 0.955 ¬± 0.007 0.874 ¬± 0.040 0.908 ¬± 0.060 0.967 ¬± 0.006 0.915 ¬± 0.010 0.910 ¬± 0.018

TransformerCPI 0.972 ¬± 0.003 0.908 ¬± 0.006 0.917 ¬± 0.005 0.980 ¬± 0.004 0.945 ¬± 0.005 0.942 ¬± 0.006

GraphsformerCPI **0.990 ¬± 0.002** **0.952 ¬± 0.004** **0.979 ¬± 0.004** **0.989 ¬± 0.003** 0.935 ¬± 0.005 **0.959 ¬± 0.004**


Bold font indicates the best result in the column


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 373


**Table 7** Comparison results of GraphsformerCPI and baselines on the Davis and KIBA datasets


Methods Davis KIBA


CI MSE Pearson CI MSE Pearson


KronRLS 0.861 ¬± 0.023 0.375 ¬± 0.031 ‚Äì 0.774 ¬± 0.061 0.420 ¬± 0.034 ‚Äì

SimBoost 0.868 ¬± 0.020 0.279 ¬± 0.035 ‚Äì 0.822 ¬± 0.040 0.254 ¬± 0.022 ‚Äì

DeepDTA 0.863 ¬± 0.022 0.270 ¬± 0.024 0.802 ¬± 0.048 0.841 ¬± 0.031 0.223 ¬± 0.020 0.807 ¬± 0.046

WideDTA 0.861 ¬± 0.023 0.312 ¬± 0.027 0.793 ¬± 0.052 0.845 ¬± 0.030 0.211 ¬± 0.019 0.803 ¬± 0.048

GraphDTA 0.875 ¬± 0.017 0.234 ¬± 0.021 0.812 ¬± 0.044 0.879 ¬± 0.015 0.183 ¬± 0.017 0.823 ¬± 0.039

DGraphDTA 0.891 ¬± 0.010 0.215 ¬± 0.025 **0.867 ¬± 0.020** 0.884 ¬± 0.013 0.152 ¬± 0.014 **0.900 ¬± 0.022**

GraphsformerCPI **0** . **910** ¬± **0** . **013** **0** . **212** ¬± **0** . **019** 0.853 ¬± 0.026 **0** . **913** ¬± **0** . **021** **0** . **141** ¬± **0** . **016** 0.891 ¬± 0.031


Bold font indicates the best result in the column


- Representations of proteins and compounds in methods: KronRLS: S-W & Pubchem Sim, SimBoost: S-W & Pubchem Sim, DeepDTA: CNN
& CNN, WideDTA: PS + PDM & LS + LMCS, GraphDTA: GIN & 1D, DGraphDTA: GCN & GCN, GraphsformerCPI: Graph+Transformer &
Graph+Transformer



**3.6 Model Interpretation**


To demonstrate the interpretability of our model, we present a case study using a two-layer GraphsformerCPI
(with 4 attention heads) and randomly select a test record
from the human dataset: acetazolamide (PubChem CID:
1986) and mitochondrial carbonic anhydrase 5B (UniProt
ID: Q9Y2D0). The canonical smiles of acetazolamide is
_CC_ (= _O_ ) _NC_ 1 = _NN_ = _C_ ( _S_ 1) _S_ (= _O_ )(= _O_ ) _N_ . It consists of
13 non-hydrogen atoms and acts as a non-competitive inhibitor of mitochondrial carbonic anhydrase 5B. Mitochondrial
carbonic anhydrase 5B comprises 317 amino acids and is
found in cells in the proximal tube of kidney, eye, and glial

cells.

Figures 5 and 6 display the self-attention distribution
of compounds and proteins. These distribution exhibit an



overall diagonal symmetry but also local asymmetry. Each
figure represent the fusion of the Laplacian matrix, Euclidean distance matrix, and semantic weight matrix. The
color differences indicate that the model assigns different
weights to local regions within the molecules, where nodes
receive varying levels of attention. This demonstrates the
effective fusion of structural and semantic features.
After two rounds of training, the model assigns lower
attention to atom pairs formed by any two atoms located
at positions 4th to 8th in the compounds, as shown in
Figs. 5e‚Äìh. This is reasonable because these five atoms
belong to a heterocycle, which exhibits stability in compound-protein interactions. This provides evidence for
the consistency between attention scores and molecular

structures.



(a) (b) (c) (d)


(e) (f) (g) (h)


**Fig. 5** Visualization of self-attention matrices of acetazolamide in the 2-layer, 4-head GraphsformerCPI


374 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377


**Fig. 6** Visualization of self-attention matrices of mitochondrial carbonic anhydrase 5B in the 2-layer, 4-head GraphsformerCPI



Furthermore, Fig. 5a‚Äìh reveal that the attention scores
at diagonal positions are not necessarily higher than those
at non-diagonal positions. This is due to the use of 1 √ó 1
convolutions in the encoder module, which promotes interaction between feature spaces and enhances the non-linear
fusion ability of attention, instead of simply summing the
Laplacian matrix, Euclidean distance matrix, and semantic
weight matrix.



Figure 7 illustrates the inter-attention between acetazolamide atoms and mitochondrial carbonic anhydrase 5B
residues in GraphsformerCPI. The _x_ -axis represents protein
residues, while the _y_ -axis represents compound atoms. In
Fig. 7a‚Äìh, the attention at the 0-layer mainly focuses on residues near positions 38th, 84th, 170th, 194th, 219th, 251th,
and 280th. After the 1-layer, the attention of the compound
atoms gradually converged towards residues near positions
84th, 192th, 219th, 221th, and 251th.



(a) (b) (c) (d)


(e) (f) (g) (h)


**Fig. 7** Visualization of attention matrices of acetazolamide and mitochondrial carbonic anhydrase 5B in the 2-layer, 4-head GraphsformerCPI


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 375



To further explore the role of inter-attention in CPIs, we
visualize the molecular docking of mitochondrial carbonic
anhydrase 5B with acetazolamide using AutoDock [49],
according to geometric and energetic complementarity.
Molecular docking is a widely used computational chemistry method to predict and understand the binding mode and
affinity between ligands and receptors. The process involves
several steps: loading the 3D structure file of mitochondrial
carbonic anhydrase 5B; performing operations such as dehydration, hydrogenation, and charge calculation for the receptor protein; loading the 3D structure file of acetazolamide;
preoperating the ligand by hydrogenation, automatic charge
distribution, detection of rotatable bonds, and selection of
torsional bonds; defining the search space for the ligand in
the protein pocket; placing the ligand at the active site of
the target protein, and continuously optimizing the positions
and conformations of the ligand molecules as well as the
dihedral angles of the rotatable bonds while adjusting the
side chains and backbone of the receptor residues to find
the optimal ligand-receptor interaction conformation and
calculate the key binding sites.
Figure 8 highlights the pocket residues in magenta and
displays the compound atoms in iridescence. Protein residues located in or around the binding pocket easily interact with the compound via hydrogen bonds, van der Waals
forces, or hydrophobic interactions. Specifically, in mitochondrial carbonic anhydrase 5B, pocket residues such as
HIS-190, CYS-219, MET-221, THR-223, and PRO-251
form hydrogen bonds with atoms of acetazolamide. The
attention distributions of compound atoms and protein residues are very close to the results of molecular docking.
As progressing from the 0-layer to the 1-layer, the
extracted features become increasingly precise. Interestingly,
Fig. 7f shows that the distribution of attention to protein
residues for compound atoms located at positions 4th to 8th
significantly deviates from that of other atoms. This may
indicate that atoms in the heterocyclic structure of the compound pay more attention to protein residues.
By visualizing residues PRO-82, THR-84, and acetazolamide in Fig. 9, we investigate the high attention scores of
acetazolamide near the 84th residue in Fig. 7h. The nearest
atomic distances of the ligand to residues PRO-82 and THR84 are 16.6 _A_ _[Ãä]_ and 14.3 _A_ _[Ãä]_, respectively. This indicates that both
residues are relatively close to the compound, leading the
model to mistakenly assign more attention to them during
the learning process.



**Fig. 8** Visualization of the binding sites of acetazolamide and mitochondrial carbonic anhydrase 5B with highlighted atoms and residues
by autodock


**Fig. 9** Visualization of residues with high attention scores of mitochondrial carbonic anhydrase 5B


**4 Conclusion**


In this study, we proposed GraphsformerCPI, a novel deep
learning framework that effectively predicts compound‚Äìprotein interactions by fusing spatial structure and semantic
information. By treating compounds and proteins as node
sequences with spatial structure, GraphsformerCPI leverages
a structure-enhanced self-attention mechanism to capture
the impact of structural and semantic features on molecular
representations. Additionally, a dual attention mechanism is
employed to uncover hidden relationship features between
compound atoms and protein residues. GraphsformerCPI
incorporates AlphaFold2 to generate contact maps in protein
feature extraction, which is rarely used in other studies. The
integration of attention mechanisms in GraphsformerCPI not
only enhances its predictive performance but also provides a
level of interpretability that is often lacking in other blackbox deep learning models. We conducted extensive evaluations of GraphsformerCPI using diverse datasets, including
human, _C. elegans_, Davis, and KIBA datasets and explored


376 Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377



the impact of model depth and dropout rate on performance.
Through comparative experiments, GraphsformerCPI exhibited higher performance to the state-of-the-art baseline models in AUC, precision, and recall on classification datasets,
and achieved competitive performance in CI and MSE on
regression datasets. Furthermore, the interpretable results of
the proposed model were compared with molecular docking
experiments, which provide a novel view for explaining the
compound‚Äìprotein interactions and binding mechanisms,
differentiating it from other black-box deep learning models.
Based on these evaluations, we can conclude that GraphsformerCPI effectively predicts CPIs and binding affinities,
which has practical implications for identifying key atoms
and residues, discovering drug candidates, and even downstream pharmaceutical tasks.


**Acknowledgements** This work is supported by Natural Science Foundation of Gansu Province, China (Project No. 21JR7RA460), the Fundamental Research Funds for the Central Universities (Project No.
lzujbky-2022-39) and National Natural Science Foundation of China
(Project No. 61702240).


**Data availability** The datasets and source code of our method can be
[downloaded at https://‚Äãgithub.‚Äãcom/‚Äãhappay-‚Äãending/‚Äãgraph‚Äãsform‚ÄãerCPI.](https://github.com/happay-ending/graphsformerCPI)


**Declarations**


**Conflict of interest** The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.


**References**


1. Sangsoo L, Yijingxiu L, Chang Yun C et al (2021) A review on
compound‚Äìprotein interaction prediction methods: Data, format,
representation and model. Comput Struct Biotechnol J 19:1541‚Äì
[1556. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äãcsbj.‚Äã2021.‚Äã03.‚Äã004](https://doi.org/10.1016/j.csbj.2021.03.004)
2. Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M et al (2020) Drug
databases and their contributions to drug repurposing. Genomics
[112:1087‚Äì1095. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äãygeno.‚Äã2019.‚Äã06.‚Äã021](https://doi.org/10.1016/j.ygeno.2019.06.021)
3. Abbasi K, Razzaghi P, Poso A et al (2021) Deep learning in drug
target interaction prediction: current and future perspectives. Curr
[Med Chem 28:2100‚Äì2113. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã2174/‚Äã09298‚Äã67327‚Äã](https://doi.org/10.2174/0929867327666200907141016)
[66620‚Äã09071‚Äã41016](https://doi.org/10.2174/0929867327666200907141016)

4. D‚ÄôSouza S, Prema KV, Balaji S (2020) Machine learning models
for drug-target interactions: current knowledge and future direc[tions. Drug Discov Today 25:748‚Äì756. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äã](https://doi.org/10.1016/j.drudis.2020.03.003)
[drudis.‚Äã2020.‚Äã03.‚Äã003](https://doi.org/10.1016/j.drudis.2020.03.003)

5. Schneider G (2010) Virtual screening: an endless staircase? Nat
[Rev Drug Discov 9:273‚Äì276. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1038/‚Äãnrd31‚Äã39](https://doi.org/10.1038/nrd3139)
6. Du B, Qin Y, Jiang Y et al (2022) Compound-protein interaction
prediction by deep learning: databases, descriptors and models.
[Drug Discov Today 27:1350‚Äì1366. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äã](https://doi.org/10.1016/j.drudis.2022.02.023)
[drudis.‚Äã2022.‚Äã02.‚Äã023](https://doi.org/10.1016/j.drudis.2022.02.023)

7. Macarron R, Banks MN, Bojanic D et al (2011) Impact of highthroughput screening in biomedical research. Nat Rev Drug Dis[cov 10:188‚Äì195. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1038/‚Äãnrd33‚Äã68](https://doi.org/10.1038/nrd3368)



8. Sadybekov AA, Sadybekov AV, Liu Y et al (2022) Synthon-based
ligand discovery in virtual libraries of over 11 billion compounds.
[Nature 601:452‚Äì459. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1038/‚Äãs41586-‚Äã021-‚Äã04220-9](https://doi.org/10.1038/s41586-021-04220-9)
9. Deane C, Mokaya M (2022) A virtual drug-screening approach
[to conquer huge chemical libraries. Nature 601:322‚Äì323. https://‚Äã](https://doi.org/10.1038/d41586-021-03682-1)
[doi.‚Äãorg/‚Äã10.‚Äã1038/‚Äãd41586-‚Äã021-‚Äã03682-1](https://doi.org/10.1038/d41586-021-03682-1)
10. Huang K, Fu T, Gao W et al (2021) Therapeutics data commons:
machine learning datasets and tasks for drug discovery and development. Proc Neural Inf Process Syst NeurIPS Datasets Bench[marks. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã48550/‚ÄãarXiv.‚Äã2102.‚Äã09548](https://doi.org/10.48550/arXiv.2102.09548)
11. Lavecchia A (2019) Deep learning in drug discovery: opportunities, challenges and future prospects. Drug Discov Today
[24:2017‚Äì2032. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äãdrudis.‚Äã2019.‚Äã07.‚Äã006](https://doi.org/10.1016/j.drudis.2019.07.006)
12. Voulodimos A, Doulamis N, Doulamis A et al (2018) Deep learning for computer vision: a brief review. Comput Intell Neurosci.
[https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1155/‚Äã2018/‚Äã70683‚Äã49](https://doi.org/10.1155/2018/7068349)
13. Li J (2022) Recent advances in end-to-end automatic speech rec[ognition. APSIPA Trans Signal Inf Process. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã](https://doi.org/10.1561/116.00000050)
[1561/‚Äã116.‚Äã00000‚Äã050](https://doi.org/10.1561/116.00000050)

14. Chen M, Firat O, Bapna A et al (2018) The best of both worlds:
Combining recent advances in neural machine translation. In:
Proceedings of the 56th annual meeting of the association for
[computational linguistics, vol 1. pp 76‚Äì86. https://‚Äãaclan‚Äãtholo‚Äãgy.‚Äã](https://aclanthology.org/P18-1008)
[org/‚ÄãP18-‚Äã1008](https://aclanthology.org/P18-1008)
15. Wu S, Sun F, Zhang W et al (2022) Graph neural networks in
recommender systems: a survey. ACM Comput Surv 55:1‚Äì37.
[https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1145/‚Äã35351‚Äã01](https://doi.org/10.1145/3535101)
16. Li J, Zheng S, Chen B et al (2016) A survey of current trends
in computational drug repositioning. Brief Bioinform 17:2‚Äì12.
[https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãbib/‚Äãbbv020](https://doi.org/10.1093/bib/bbv020)
17. Weininger D (1988) Smiles, a chemical language and information system. 1. Introduction to methodology and encoding rules.
[J Chem Inf Comput Sci 28:31‚Äì36. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1021/‚Äãci000‚Äã](https://doi.org/10.1021/ci00057a005)
[57a005](https://doi.org/10.1021/ci00057a005)

18. Pearson WR, Lipman DJ (1988) Improved tools for biological
[sequence comparison. Proc Natl Acad Sci 85:2444‚Äì2448. https://‚Äã](https://doi.org/10.1073/pnas.85.8.2444)
[doi.‚Äãorg/‚Äã10.‚Äã1073/‚Äãpnas.‚Äã85.8.‚Äã2444](https://doi.org/10.1073/pnas.85.8.2444)
19. LeCun Y, Bengio Y, Hinton G (2015) Deep learning. Nature
[521:436‚Äì44. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1038/‚Äãnatur‚Äãe14539](https://doi.org/10.1038/nature14539)
20. Sherstinsky A (2020) Fundamentals of recurrent neural network
(RNN) and long short-term memory (LSTM) network. Physica D
[Nonlinear Phenom 404:132306. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äãphysd.‚Äã](https://doi.org/10.1016/j.physd.2019.132306)
[2019.‚Äã132306](https://doi.org/10.1016/j.physd.2019.132306)

21. Kiranyaz S, Avci O, Abdeljaber O et al (2021) 1D convolutional
neural networks and applications: a survey. Mech Syst Signal Pro[cess 151:107398. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äãymssp.‚Äã2020.‚Äã107398](https://doi.org/10.1016/j.ymssp.2020.107398)
22. Vaswani A, Shazeer N, Parmar N et al (2017) Attention is all you
[need. In: NIPS‚Äô17 6000-6010. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã48550/‚ÄãarXiv.‚Äã](https://doi.org/10.48550/arXiv.1706.03762)
[1706.‚Äã03762](https://doi.org/10.48550/arXiv.1706.03762)
23. √ñzt√ºrk H, √ñzg√ºr A, Ozkirimli E (2018) DeepDTA: deep drugtarget binding affinity prediction. Bioinformatics 34:i821‚Äìi829.
[https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãbioin‚Äãforma‚Äãtics/‚Äãbty593](https://doi.org/10.1093/bioinformatics/bty593)
24. Wan F, Zhu Y, Hu H et al (2019) DeepCPI: a deep learning-based
framework for large-scale in silico drug screening. Genom Pro[teom Bioinform 17:478‚Äì495. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1016/j.‚Äãgpb.‚Äã2019.‚Äã](https://doi.org/10.1016/j.gpb.2019.04.003)
[04.‚Äã003](https://doi.org/10.1016/j.gpb.2019.04.003)
25. Karimi M, Wu D, Wang Z et al (2019) DeepAffinity: interpretable deep learning of compound-protein affinity through unified
recurrent and convolutional neural networks. Bioinformatics

[35:3329‚Äì3338. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãbioin‚Äãforma‚Äãtics/‚Äãbtz111](https://doi.org/10.1093/bioinformatics/btz111)
26. Chen L, Tan X, Wang D et al (2020) TransformerCPI: improving compound-protein interaction prediction by sequence-based
deep learning with self-attention mechanism and label reversal
[experiments. Bioinformatics 36:4406‚Äì4414. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã](https://doi.org/10.1093/bioinformatics/btaa524)
[1093/‚Äãbioin‚Äãforma‚Äãtics/‚Äãbtaa5‚Äã24](https://doi.org/10.1093/bioinformatics/btaa524)


Interdisciplinary Sciences: Computational Life Sciences (2024) 16:361‚Äì377 377



27. Wang Y, You Z, Yang S et al (2020) A deep learning-based
method for drug-target interaction prediction based on long
short-term memory neural network. BMC Med Inf Decis Mak
[20:49. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1186/‚Äãs12911-‚Äã020-‚Äã1052-0](https://doi.org/10.1186/s12911-020-1052-0)
28. Jin W, Barzilay R, Jaakkola T (2018) Junction tree variational
autoencoder for molecular graph generation. In: Proceedings of
the 35th international conference on machine learning, vol 80.
[pp 2323‚Äì2332. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã48550/‚ÄãarXiv.‚Äã1802.‚Äã04364](https://doi.org/10.48550/arXiv.1802.04364)
29. Nguyen T, Le H, Quinn TP et al (2020) GraphDTA: predicting
drug-target binding affinity with graph neural networks. Bio[informatics 37:1140‚Äì1147. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãbioin‚Äãforma‚Äã](https://doi.org/10.1093/bioinformatics/btaa921)
[tics/‚Äãbtaa9‚Äã21](https://doi.org/10.1093/bioinformatics/btaa921)

30. Wang E, Wang F, Yang Z et al (2020) A graph convolutional
network-based method for chemical-protein interaction extraction: algorithm development. JMIR Med Inform 8:e17643.
[https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã2196/‚Äã17643](https://doi.org/10.2196/17643)
31. Tsubaki M, Tomii K, Sese J (2018) Compound-protein interaction prediction with end-to-end learning of neural networks for
[graphs and sequences. Bioinformatics 35:309‚Äì318. https://‚Äãdoi.‚Äã](https://doi.org/10.1093/bioinformatics/bty535)
[org/‚Äã10.‚Äã1093/‚Äãbioin‚Äãforma‚Äãtics/‚Äãbty535](https://doi.org/10.1093/bioinformatics/bty535)
32. Torng W, Altman RB (2019) Graph convolutional neural networks for predicting drug-target interactions. J Chem Inf Model
[59:4131‚Äì4149. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1021/‚Äãacs.‚Äãjcim.‚Äã9b006‚Äã28](https://doi.org/10.1021/acs.jcim.9b00628)
33. Jiang M, Li Z, Zhang S et al (2020) Drug-target affinity prediction using graph neural network and contact maps. RSC Adv
[10:20701‚Äì20712. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1039/‚ÄãD0RA0‚Äã2297G](https://doi.org/10.1039/D0RA02297G)
34. Landrum G (2013) RDKit: open-source cheminformatics.
[Release 1:4. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã5281/‚Äãzenodo.‚Äã591637](https://doi.org/10.5281/zenodo.591637)
35. Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with alphafold. Nature 596:583‚Äì589.
[https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1038/‚Äãs41586-‚Äã021-‚Äã03819-2](https://doi.org/10.1038/s41586-021-03819-2)
36. Li Y, Hsieh C, Lu R et al (2022) An adaptive graph learning
method for automated molecular interactions and properties pre[dictions. Nat Mach Intell 4:645‚Äì651. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1038/‚Äã](https://doi.org/10.1038/s42256-022-00501-8)
[s42256-‚Äã022-‚Äã00501-8](https://doi.org/10.1038/s42256-022-00501-8)

37. Davis MI, Hunt JP, Herrgard S et al (2011) Comprehensive
analysis of kinase inhibitor selectivity. Nat Biotechnol 29:1046‚Äì
[1051. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1038/‚Äãnbt.‚Äã1990](https://doi.org/10.1038/nbt.1990)
38. Tang J, Szwajda A, Shakyawar S et al (2014) Making sense of
large-scale kinase inhibitor bioactivity data sets: a comparative
[and integrative analysis. J Chem Inf Model 54:735‚Äì743. https://‚Äã](https://doi.org/10.1021/ci400709d)
[doi.‚Äãorg/‚Äã10.‚Äã1021/‚Äãci400‚Äã709d](https://doi.org/10.1021/ci400709d)
39. Huang L, Lin J, Liu R et al (2022) CoaDTI: multi-modal
co-attention based framework for drug-target interaction



[annotation. Brief Bioinform 23:bbac446. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã](https://doi.org/10.1093/bib/bbac446)
[1093/‚Äãbib/‚Äãbbac4‚Äã46](https://doi.org/10.1093/bib/bbac446)

40. Liu H, Sun J, Guan J et al (2015) Improving compound-protein
interaction prediction by building up highly credible negative
[samples. Bioinformatics 31:i221‚Äìi229. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äã](https://doi.org/10.1093/bioinformatics/btv256)
[bioin‚Äãforma‚Äãtics/‚Äãbtv256](https://doi.org/10.1093/bioinformatics/btv256)

41. Wishart DS, Knox C, Guo AC et al (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids
[Res 36:D901‚ÄìD906. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãnar/‚Äãgkm958](https://doi.org/10.1093/nar/gkm958)
42. G√ºnther S, Kuhn M, Dunkel M et al (2007) SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic
[Acids Res 36:D919‚ÄìD922. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãnar/‚Äãgkm862](https://doi.org/10.1093/nar/gkm862)
43. Kuhn M, Szklarczyk D, Pletscher-Frankild S et al (2013) STITCH
4: integration of protein‚Äìchemical interactions with user data.
[Nucleic Acids Res 42:D401‚ÄìD407. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãnar/‚Äã](https://doi.org/10.1093/nar/gkt1207)
[gkt12‚Äã07](https://doi.org/10.1093/nar/gkt1207)
44. He T, Heidemeyer M, Ban F et al (2017) SimBoost: a read-across
approach for predicting drug-target binding affinities using gradi[ent boosting machines. J Cheminform 9:1‚Äì14. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã](https://doi.org/10.1186/s13321-017-0209-z)
[1186/‚Äãs13321-‚Äã017-‚Äã0209-z](https://doi.org/10.1186/s13321-017-0209-z)

45. G√∂nen M, Heller G (2005) Concordance probability and discriminatory power in proportional hazards regression. Biometrika
[92:965‚Äì970. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1093/‚Äãbiomet/‚Äã92.4.‚Äã965](https://doi.org/10.1093/biomet/92.4.965)
[46. Wikipedia (2023) Pearson correlation coefficient. https://‚Äãen.‚Äãwikip‚Äã](https://en.wikipedia.org/wiki/Pearson_correlation_coefficient)

[edia.‚Äãorg/‚Äãwiki/‚ÄãPears‚Äãon_‚Äãcorre‚Äãlation_‚Äãcoeff‚Äãicient](https://en.wikipedia.org/wiki/Pearson_correlation_coefficient)
47. Nascimento AC, Prud√™ncio RB, Costa IG (2016) A multiple kernel learning algorithm for drug-target interaction prediction. BMC
[Bioinform 17:46. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1186/‚Äãs12859-‚Äã016-‚Äã0890-3](https://doi.org/10.1186/s12859-016-0890-3)
48. √ñzt√ºrk H, Ozkirimli E, √ñzg√ºr A (2019) WideDTA: prediction of
[drug-target binding affinity. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã48550/‚ÄãarXiv.‚Äã1902.‚Äã](https://doi.org/10.48550/arXiv.1902.04166)
[04166](https://doi.org/10.48550/arXiv.1902.04166)

49. Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and
AutoDockTools4: automated docking with selective receptor flex[ibility. J Comput Chem 30:2785‚Äì91. https://‚Äãdoi.‚Äãorg/‚Äã10.‚Äã1002/‚Äãjcc.‚Äã](https://doi.org/10.1002/jcc.21256)
[21256](https://doi.org/10.1002/jcc.21256)


Springer Nature or its licensor (e.g. a society or other partner) holds
exclusive rights to this article under a publishing agreement with the
author(s) or other rightsholder(s); author self-archiving of the accepted
manuscript version of this article is solely governed by the terms of
such publishing agreement and applicable law.


